Results
26,158 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 |  Robert E. LattaRSpouse |  FMAOFARMERS & MERCHANTS BANCORP INCPurchase | BUY | $1,001 – $15K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Robert E. LattaRSpouse | FMAOFARMERS & MERCHANTS BANCORP INC Purchase | BUY | $1,001 – $15K |
| Apr 24, 2026 traded Apr 20, 2026 |
| 21 | Reid Jeffrey A.EVP, Chief HR Officer |  BOKFBOK FINANCIAL CORPOpen-market sale | SELL | $14K 105 sh | Apr 24, 2026 traded Apr 23, 2026 |
| 19 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $269K 19.1K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 14 | Patel Rahul G.Director, See remarks below |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $205K 2,281 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 11 | Hamilton James CChief Medical Officer |  ARWRARROWHEAD PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $750K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 9 | McDonough ClaireChief Financial Officer |  RIVNRivian Automotive, Inc. / DEOpen-market sale · 10b5-1 plan | SELL | $184K 10.2K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 6 | Gibson ChristopherDirector |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $144K 40.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $267K 19.1K sh | Apr 24, 2026 traded Apr 24, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $262K 19.1K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,250 sh | Apr 24, 2026 traded Apr 24, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $31K 10.0K sh | Apr 24, 2026 traded Apr 22, 2026 |
| 3 | O'Hara John CharlesDirector, Chief Financial Officer | LAESSEALSQ Corp Open-market sale · 10b5-1 plan | SELL | $29K 10.0K sh | Apr 24, 2026 traded Apr 23, 2026 |
| 44 | Intrator Michael NDirector, CEO and President, 10% Owner |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $1.43M 12.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 44 | Hoag Erik DChief Financial Officer |  TNLTravel & Leisure Co.Open-market purchase | BUY | $66K 1,000 sh | Apr 23, 2026 traded Apr 23, 2026 |
| 43 | Sharma SanjaySee Remarks* |  SEICSEI INVESTMENTS COOpen-market sale | SELL | $2.11M 23.4K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 41 | Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER |  SGMOSANGAMO THERAPEUTICS, INCOpen-market sale | SELL | $89K 345.9K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 41 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $388K 3,255 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.57M 22.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.83M 15.5K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 40 | Peterson MichaelEXECUTIVE VICE PRESIDENT | SEICSEI INVESTMENTS CO Open-market sale | SELL | $900K 10.0K sh | Apr 23, 2026 traded Apr 23, 2026 |
| 40 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $5.66M 49.0K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 39 | Patrick Deval LDirector |  TOSTToast, Inc.Open-market sale | SELL | $62K 1,667 sh | Apr 23, 2026 traded Jan 9, 2025 |
| 37 | Schnurman JoshTreasurer | NAColler Secondaries Private Equity Opportunities Fund Open-market purchase | BUY | $15K 2,595 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 35 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 350 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 35 | Mindlin Marcos MarceloDirector, 10% Owner |  PAMPampa Energy Inc.Open-market sale | SELL | $5.27M 1.50M sh | Apr 23, 2026 traded Apr 22, 2026 |
| 35 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $10.51M 90.9K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 34 | Davis Gregory DHead of Research & Technology | SGMOSANGAMO THERAPEUTICS, INC Open-market sale | SELL | $18K 69.8K sh | Apr 23, 2026 traded Apr 22, 2026 |
| 33 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $620K 5,404 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 32 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.15M 10.0K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 32 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3.39M 28.8K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 32 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.65M 22.4K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 32 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $4.78M 41.1K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 29 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $721K 6,045 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 29 | Sharma SanjaySee Remarks* | SEICSEI INVESTMENTS CO Open-market sale | SELL | $141K 1,559 sh | Apr 23, 2026 traded Apr 23, 2026 |
| 26 | Rote William E.Chief Research Officer |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $356K 9,100 sh | Apr 23, 2026 traded Apr 22, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $78K 650 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 25 | Greenberg Aaron SamuelCSO |  NYAXNayax Ltd.Open-market sale | SELL | $64K 1,002 sh | Apr 23, 2026 traded Apr 22, 2026 |
| 25 | Neagle MatthewChief Operating Officer |  PRCHPorch Group, Inc.Open-market sale | SELL | $510K 62.8K sh | Apr 23, 2026 traded Apr 21, 2026 |
| 25 | Yoshiyama AnnieSVP, Finance |  ALLOAllogene Therapeutics, Inc.Open-market sale | SELL | $22K 9,586 sh | Apr 23, 2026 traded Apr 21, 2026 |
| 25 | Manor SagitCFO | NYAXNayax Ltd. Open-market sale | SELL | $112K 1,754 sh | Apr 23, 2026 traded Apr 22, 2026 |